Monitor
Book
Fórum
Rankings
Portfolio
Mercados
Scanner
Menu
Dados
Monitor
Book
Gráficos
Opções
Balanços
Dividendos
Histórico
Notícias
Jornal ADVFN
News Scanner
Alerta de Notícias
Ferramentas
Scanner
Follow Feed
Alertas
Trader Alerts
Conversor
DDE
Mercados
Forex
Crypto
Futuros
Opções EUA
Commodities
Bolsas
Comunidade
Fórum
Agenda Ecônomia
PlusOneCoin
Assine
Login/Cadastro
Suporte
(11) 4950 5808
suporte@advfn.com.br
Índice Bovespa
114.352,31
(
1,47%
)
S&P 500
4.282,35
(
0,2%
)
US Dollar vs BRL
4,9103
(
-0,34%
)
Bitcoin
26.110,65
(
1,35%
)
Brent Oil
76,145
(
-0,41%
)
Início
Investir
Ações
EUA
NASDAQ
Moderna Inc
(MRNA)
Moderna Inc
(MRNA)
Balanços
MRNA
Moderna Inc
Moderna Inc (NASDAQ)
Moderna Inc(BIT)
Morson.Asd Cash(LSE)
128,979
0,079
(
0,06%
)
Upgrade para Tempo Real
Cotação
Gráfico
Book
Notícias
Negócios
Opções
Novo
Balanços
Mais
Histórico
Financials
Ficha Setorial
Pesquisar por Setor
FiltroX
Moderna Inc. (MRNA) Fundamentals
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
SHARE INFORMATION
Market Cap
US$ 49.137.884.055
Shares Outstanding
381.209.341
Float
331.830.000
Percent Float
87,05%
Short Interest
0,00
Short Percent Float
0,0%
Short Interest Ratio
0,00
Short Interest Date
-
Latest Fiscal Dividend Per Share
US$ 0,00
Latest Fiscal Revenue
US$ 1.862.000.000
Latest Fiscal EPS
US$ 0,20
Latest Fiscal Date
2023-03-31
DIVIDENDS
Dividend (3 Years)
US$ 0,00
Dividend (5 Years)
US$ 0,00
Ex Dividend Date
-
Dividend Rate
US$ 0,00
Dividend Yield
0,0%
Payment Cash
-
HOLDERS
Institutions
2.282
Institutional Holdings Date
2023-03-31
Institutional Bought Previous 3 Months
20.400.654
Institutional Holdings Percent
114,0%
Institutional Sold Previous 3 Months
32.301.543
Insider Holdings Date
2023-03-31
Insider Bought Previous 3 Months
1.047.606
Insider Holdings Percent
3,8
Insider Sold Previous 3 Months
1.697.050
Insider Shares Owned
14.725.952
TRADING INFO
52 Week High
US$ 217,25
52 Week Low
US$ 115,03
52 Week High Change
US$ -6,02
21 Day Moving Average
US$ 129,3776
21 Day Extended Moving Average
US$ 130,4474
50 Day Moving Average
US$ 138,7554
50 Day Extended Moving Average
US$ 137,2227
200 Day Moving Average
US$ 153,606
200 Day Extended Moving Average
US$ 154,8281
10 Day Average Volume
3.664.394
20 Day Average Volume
3.247.848
30 Day Average Volume
3.320.388
50 Day Average Volume
3.364.467
Alpha
0.051343
Beta
1.6974
Standard Deviation
0.273983
R2
0.112639
7 Day Price Change
US$ 2,66
7 Day Percent Change
2,11%
21 Day Price Change
US$ -1,36
21 Day Percent Change
-1,04%
30 Day Price Change
US$ -8,14
30 Day Percent Change
-5,94%
Month to Date Price Change
US$ 1,19
Month to Date Percent Change
0,93%
Quarter to Date Price Change
US$ -24,68
Quarter to Date Percent Change
-16,07%
180 Day Price Change
US$ -47,03
180 Day Percent Change
-26,73%
200 Day Price Change
US$ -55,00
200 Day Percent Change
-29,91%
Year to Date Price Change
US$ -50,72
Year to Date Percent Change
-28,24%
Moderna Inc. (MRNA) Key Ratios
PROFITABILITY
EBIT Margin
22,3%
EBITDA Margin
24,1%
Pre-Tax Profit Margin
54,0%
Profit Margin Count
0,04%
Gross Margin
64,8%
Profit Margin TOT
0,04%
INCOME STATEMENTS
Revenue
US$ 1.862.000.000
Revenue Per Share
US$ 4,8845
Revenue (3 Years)
US$ 0,00
Revenue (5 Years)
US$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book
2,60
Total Debt To Equity
0,10
Int Coverage
84,70
Current Ratio
3,50
Leverage Ratio
1,30
Quick Ratio
2,90
Long Term Debt To Capital
0,05
VALUATION MEASURES
PE Ratio
10,20
Enterprise Value
US$ 41.917.631.094
Price to Sales
3,30
Price to Free Cash
0,00
PE High Last 5 Years
0,00
Price To Book
2,60
Price To Cash Flow
-9,90
PE Low Last 5 Years
0,00
Price to Tangible Book
2,60
MANAGEMENT EFFECTIVENESS
Receivables Turnover
6,90
Invoice Turnover
3,90
Assets Turnover
0,60
Return Assets
18,49
Return on Equity
26,74
Return on Capital
17,76
Moderna Inc. (MRNA) Profile
PROFILE INFO
Issue Type
CS
SEC Type
-
Auditor
-
CEO
Stephane Bancel
Employees
2700
Last Audit
-
CIK
0001682852
Industry
Biotechnology
Sector
Healthcare
NAICS
Biological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address
200 Technology Square
Cambridge, MA 2139
Website
https://www.modernatx.com
Facsimile
+1 617 583-1998
Telephone
+1 617 714-6500
Email
Lavina.Talukdar@modernatx.com
Seu Histórico Recente
NASDAQ
MRNA
Moderna
Registre-se agora
para acompanhar essas ações ao vivo no Monitor ADVFN.
O Monitor permite ver até 110 de suas ações favoritas de uma vez só e é
completamente grátis
para você usar.
Faça o login em ADVFN
Registrar agora
Cotações da NYSE e AMEX têm defasagem de no mínimo 20 minutos.
Quaisquer outras cotações têm defasagem de no mínimo 15 minutos quando não especificado.
Em caso de dúvidas por favor entre em contato com o suporte:
suporte@advfn.com.br
ou (11) 4950 5808.